Clincosm LogoSign in Get a demo

Neoplasms

Showing NaN - NaN of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Worldwide (Letetresgene autoleucel)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 7, 2023

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Tumors Trial in Worldwide (Encorafenib, Cetuximab, Oxaliplatin)

Recruiting
  • Neoplasms
  • Phoenix, Arizona
  • +396 more
Jan 25, 2023

Tumors Trial in Spain, United Kingdom, United States (BI 1387446, BI 754091)

Active, not recruiting
  • Neoplasms
  • BI 1387446
  • BI 754091
  • Chapel Hill, North Carolina
  • +7 more
Jan 23, 2023

Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)

Recruiting
  • Neoplasms
  • BI 907828
  • +2 more
  • Santa Monica, California
  • +16 more
Jan 23, 2023

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Tumors Trial in Canada, United Kingdom, United States (BI 754091)

Active, not recruiting
  • Neoplasms
  • BI 754091
  • Sarasota, Florida
  • +12 more
Jan 9, 2023

Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

Active, not recruiting
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • BI 754111
  • BI 754091
  • Miami, Florida
  • +14 more
Jan 9, 2023

Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

Recruiting
  • Neoplasms
  • Brno, Czechia
  • +20 more
Nov 21, 2022

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

Anticoagulation in Venous Thromboembolism and Cancer

Active, not recruiting
  • Neoplasms
  • Embolism
  • London, United Kingdom
    Pfizer Investigational Site
Nov 17, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel (lete-cel, GSK3377794)
  • +2 more
  • Duarte, California
  • +36 more
Oct 28, 2022

Tumors Trial in Worldwide (JNJ-63723283)

Recruiting
  • Neoplasms
  • Saint Louis, Missouri
  • +32 more
Aug 11, 2022

Tumors Trial in Worldwide (Biopsy)

Completed
  • Neoplasms
  • Biopsy
  • San Francisco, California
  • +10 more
Aug 10, 2022

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Information Needs Around Parenteral nUTrition in Cancer

Completed
  • Cancer
  • +6 more
  • Non-interventional study
  • London, United Kingdom
  • +3 more
Jul 14, 2022

Tumor Metastasis, Neoplastic Processes, Tumors Trial in Canada (SUPR, VMAT)

Recruiting
  • Neoplasm Metastasis
  • +3 more
  • SUPR
  • VMAT
  • Prince George, British Columbia, Canada
  • +4 more
Apr 6, 2022

Tumors Trial in Worldwide (Everolimus, Exemestane, BI 836845)

Completed
  • Neoplasms
  • Graz, Austria
  • +37 more
Feb 2, 2022

Tumors Trial in Worldwide (GSK adoptive cell therapy)

Recruiting
  • Neoplasms
  • GSK adoptive cell therapy
  • Duarte, California
  • +37 more
Feb 1, 2022

Tumors Trial in Worldwide (GSK525762, Placebo, Fulvestrant)

Completed
Has Results
  • Neoplasms
  • Birmingham, Alabama
  • +38 more
Nov 18, 2021

Tumors Trial in Worldwide (Oral daily administration of BAL101553)

Recruiting
  • Neoplasms
  • Oral daily administration of BAL101553
  • Leuven, Belgium
  • +12 more
Jan 19, 2022

iKnife REIMS Project

Recruiting
  • Neoplasms
  • Neoplasm Malignant
  • Rapid Evaporative Ionisation Mass Spectrometry (REIMS)
  • London, United Kingdom
  • +1 more
Sep 1, 2021